ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
23 years of mTOR inhibition for tuberous sclerosis: Practical considerations.
David Neal FranzPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.